These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 34547850)
61. Effect of melasma on quality of life in a sample of women living in southern Brazil. Freitag FM; Cestari TF; Leopoldo LR; Paludo P; Boza JC J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):655-62. PubMed ID: 18410339 [TBL] [Abstract][Full Text] [Related]
63. Validation of a melasma quality of life questionnaire for Brazilian Portuguese language: the MelasQoL-BP study and improvement of QoL of melasma patients after triple combination therapy. Cestari TF; Hexsel D; Viegas ML; Azulay L; Hassun K; Almeida AR; RĂªgo VR; Mendes AM; Filho JW; Junqueira H Br J Dermatol; 2006 Dec; 156 Suppl 1():13-20. PubMed ID: 17176300 [TBL] [Abstract][Full Text] [Related]
64. Melasma. Etiologic and therapeutic considerations. Grimes PE Arch Dermatol; 1995 Dec; 131(12):1453-7. PubMed ID: 7492140 [TBL] [Abstract][Full Text] [Related]
65. Melasma: a clinical, light microscopic, ultrastructural, and immunofluorescence study. Sanchez NP; Pathak MA; Sato S; Fitzpatrick TB; Sanchez JL; Mihm MC J Am Acad Dermatol; 1981 Jun; 4(6):698-710. PubMed ID: 6787100 [TBL] [Abstract][Full Text] [Related]
66. French maritime pine bark extract (pycnogenol) in association with triple combination cream for the treatment of facial melasma in women: a double-blind, randomized, placebo-controlled trial. Lima PB; Dias JAF; Esposito ACC; Miot LDB; Miot HA J Eur Acad Dermatol Venereol; 2021 Feb; 35(2):502-508. PubMed ID: 32841433 [TBL] [Abstract][Full Text] [Related]
67. Dermoscopy as a useful tool for evaluating melasma and assessing the response to 1064-nm Q-switched Nd:YAG laser. Abdel Hay R; Mohammed FN; Sayed KS; Abd El Fattah NA; Ibrahim S Dermatol Ther; 2020 Jul; 33(4):e13629. PubMed ID: 32431000 [TBL] [Abstract][Full Text] [Related]
68. Role of oxidative stress in melasma: a prospective study on serum and blood markers of oxidative stress in melasma patients. Choubey V; Sarkar R; Garg V; Kaushik S; Ghunawat S; Sonthalia S Int J Dermatol; 2017 Sep; 56(9):939-943. PubMed ID: 28681382 [TBL] [Abstract][Full Text] [Related]
69. Efficacy of Trichloro-Acetic Acid Peel Alone Versus Combined Topical Magnesium Ascorbyl Phosphate for Epidermal Melasma. Murtaza F; Bangash AR; Khushdil A; Noor SM J Coll Physicians Surg Pak; 2016 Jul; 26(7):557-61. PubMed ID: 27504543 [TBL] [Abstract][Full Text] [Related]
70. Serum iron level, ferritin and total iron binding capacity level among nonpregnant women with and without melasma. Behrangi E; Baniasadi F; Esmaeeli S; Hedayat K; Goodarzi A; Azizian Z J Res Med Sci; 2015 Mar; 20(3):281-3. PubMed ID: 26109976 [TBL] [Abstract][Full Text] [Related]
71. Estrogen receptor expression in melasma: results from facial skin of affected patients. Lieberman R; Moy L J Drugs Dermatol; 2008 May; 7(5):463-5. PubMed ID: 18505139 [TBL] [Abstract][Full Text] [Related]
72. Association between heterozygote Val92Met Suryaningsih BE; Sadewa AH; Wirohadidjojo YW; Soebono H Clin Cosmet Investig Dermatol; 2019; 12():489-495. PubMed ID: 31308719 [No Abstract] [Full Text] [Related]
74. Investigator-Blinded, Single-Center Study to Evaluate the Efficacy and Tolerability of a 4% Hydroquinone Skin Care System Plus 0.02% Tretinoin Cream in Mild-to-Moderate Melasma and Photodamage. Rendon M; Dryer L J Drugs Dermatol; 2016 Apr; 15(4):466-75. PubMed ID: 27050702 [TBL] [Abstract][Full Text] [Related]
75. Knowledge and attitude on prevention of COVID-19 among community health workers in Nepal-a cross-sectional study. Shrestha A; Thapa TB; Giri M; Kumar S; Dhobi S; Thapa H; Dhami PP; Shahi A; Ghimire A; Rathaur ES BMC Public Health; 2021 Jul; 21(1):1424. PubMed ID: 34281512 [TBL] [Abstract][Full Text] [Related]
76. Development and validation of a Hindi language health-related quality of life questionnaire for melasma in Indian patients. Sarkar R; Garg S; Dominguez A; Balkrishnan R; Jain RK; Pandya AG Indian J Dermatol Venereol Leprol; 2016; 82(1):16-22. PubMed ID: 26728805 [TBL] [Abstract][Full Text] [Related]
77. Melasma Treatment: An Evidence-Based Review. McKesey J; Tovar-Garza A; Pandya AG Am J Clin Dermatol; 2020 Apr; 21(2):173-225. PubMed ID: 31802394 [TBL] [Abstract][Full Text] [Related]
78. Exposure factors in the occurrence and development of melasma (Review). Chen Y; Vellaichamy G; Schneider SL; Kong W; Liu Z Exp Ther Med; 2024 Apr; 27(4):131. PubMed ID: 38414788 [TBL] [Abstract][Full Text] [Related]
79. Correlation of biorhythmic disorders with melasma: A cross-sectional survey. He X; Chen L; Jin S; Ding Y; Xu Z; Xiang L; Zhang C J Am Acad Dermatol; 2024 Oct; ():. PubMed ID: 39374809 [No Abstract] [Full Text] [Related]
80. Clinico-etiological Profile of Melasma among Female Health Workers in a Tertiary Care Center of Central Nepal - A Cross Sectional Study. Karn D; Subedi A; Kc S Kathmandu Univ Med J (KUMJ); 2017; 17(58):160-163. PubMed ID: 34547850 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]